Work

Production, characterization & bioactivity of lyophilized and spray dried platelet lysates from expired platelet concentrates

Year: 2023
Type: dissertation
Abstract: Xeno-free serum alternatives to Fetal Bovine Serum (FBS) for in vitro cellular expansion has long been a subject of scientific focus for use within regenerative medicine. Utilizing blood bank leftover platelet concentrates to produce biomarker-rich platelet lysate is one such alternative that shows the potential to become a new staple of cell-based therapies. \n Human platelet lysate (hPL) contains high amounts of the necessary growth factors for development of MSC cultures and offers to remove the risks of xeno-contaminants, inherent great batch variety and animal cruelty side effects of FBS usage and production. However, it is still a product in development and its methodology is not standardized, leading to variation in study outcomes between institutions. And local production methods often fall short of internationally acceptable quality standards. \n A standalone standard operating procedure (SOP) for production of Pathogen Inactivated Platelet Lysate (PIPL), accompanied by a Certificate of Analysis (COA) blueprint was designed based on the work of previous students, aspiring to current Good Laboratory Practice (cGLP). \nThe PIPL created from the SOP was stored at a either frozen (-20oC), lyophilized or spray dried state, after which all three PIPL products were comparatively characterized through BCA Total Protein assay, ELISAs and complete protein profiling through proteomics. The bioactive capability of the PIPL products were also tested on MC3T3 (subclone 4) osteoprogenitor cells, testing overall cell viability, cytotoxic response, and cell migration. \n Frozen PIPL and lyophilized PIPL (L-PIPL) showed comparative results across most characterization assays, while spray dried PIPL (S-PIPL) measured a significant loss of dry matter as a result of the spray drying process. While this difference was visible across most characterization data, TGF-β displayed comparable levels across all three product variants despite the lost dry matter of S-PIPL. Proteomic data indicated a significant different between product variants. \n All product variants were capable of base cellular proliferation, with PIPL and L-PIPL showing significantly higher cytotoxic values than S-PIPL, and the Wound Healing assay showed PIPL performing slower cell migration than both L-PIPL and S-PIPL. \n This thesis indicates that the usage of lyophilization and spray drying techniques are both viable methods of biomarker preservation of PIPL and can function as serum substitutes for FBS for base cellular proliferation.
Source: Skemman
Author: Kasper Bruun Lövenstein
Language: English
Subfield: Periodontics
Field: Dentistry
Open Access status: green
OpenAlex ID: W7061374804
Cites: 107
Cited by:
Related to: 9